By InvitationNot Applicable

Testing a Multilevel, Culturally Appropriate Lifestyle Intervention For Hispanic Patients With Metabolic Dysfunction-associated Steatotic Liver Disease

United States64 participantsStarted 2026-01-29

Plain-language summary

The purpose of this study is to understand if a behavioral lifestyle intervention called the Healthy Liver/Hígado Sano program can help Hispanic/Latino patients with metabolic dysfunction associated steatotic liver disease (MASLD), also known as non-alcoholic fatty liver disease (NAFLD), lose weight and improve their liver health

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Self-reported Hispanic/Latino * Have been diagnosed with MASLD * Be an adult \>= 18 years of age * Able to speak English or Spanish * Have a working telephone number * Have access to internet, either on their phone, at home or at some other location convenient to the participant * Have a family member willing to attend all sessions Exclusion Criteria: * Taking a GLP-1 receptor agonist or dual agonist at the time of enrollment, or plans to being taking one in the next 6 months

What they're measuring

Recruitment Feasibility

Timeframe: Baseline

Retention

Timeframe: 6 months, 12 months

Adherence

Timeframe: 6 months

Participant satisfaction

Timeframe: 6 months

Trial details

NCT IDNCT07199491

SponsorThe University of Texas Health Science Center, Houston

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-10-31

View on ClinicalTrials.gov More Metabolic-dysfunction Associated Liver Disease (MASLD) trials